Skip to content
Boost Up Blog – Lifestyle
Author:
AEON Biopharma Inc
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
March 25, 2026
AEON Biopharma Appoints John Bencich as Chief Financial Officer
March 9, 2026
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
March 5, 2026
←
Previous Page
1
2